Patent · US Active

Test method

US11129976B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 24, 2017
Grant dateSep 28, 2021
Priority date
Expiry dateMay 5, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/24132
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The object of the present invention is to provide a test method using a novel administration method of an extract from inflamed tissues inoculated with vaccinia virus or a preparation containing the extract. It has been demonstrated that by sustainedly administering an extract from inflamed tissues inoculated with vaccinia virus or a preparation containing the extract by using a continuous administration device according to the present invention, a comparable effect is exerted at a very low dose compared with conventional administration methods such as oral administration. Therefore, the present invention can provide a test method using animals requiring less burden on a researcher, a treatment of patient at a low dose, and the like.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.